Concepedia

Author

Jean‐Eric Charoin

Roche (Switzerland)

Also Known As

J CHAROIN, J.-E. Charoin, Jean-Eric Charoin, Jean‐Eric Charoin

13

Publications

279

Citations

8

H-Index

12

Concepts

All Affiliations

Roche (Switzerland)La Roche CollegeRoche (United Kingdom)
JC

About

Jean‐Eric Charoin is an author at Roche (Switzerland) specializing in pharmacotherapy, pharmacokinetics, and pharmacokinetic modeling.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

2

2

142

2

Pharmacology

2

2

142

3

Nephrology

1

1

22

4

Hemodialysis

1

1

22

5

Pharmacodynamic Modeling

1

1

22

Jean‐Eric Charoin

×

6

Publications

255

Citations

6

H-Index

YearCitations

The effects of CYP3A4 inhibition on erlotinib pharmacokinetics: computer-based simulation (SimCYP™) predicts in vivo metabolic inhibition

Ashok Rakhit, Michael Pantze, Scott Fettner,

European Journal of Clinical Pharmacology

2007

120

Models and Machines: How Deep Learning Will Take Clinical Pharmacology to the Next Level

Lucy Hutchinson, Bernhard Steiert, Antoine Soubret,

CPT Pharmacometrics & Systems Pharmacology

2018

51

Rituximab Exhibits a Long Half-Life Based on a Population Pharmacokinetic Analysis in Non-Hodgkin’s Lymphoma (NHL) Patients.

Jing Li, Micha Levi, Jean‐Eric Charoin,

Blood

2007

28

Assessment of the bioequivalence of two nelfinavir tablet formulations under fed and fasted conditions in healthy subjects

Benoite Kaeser, Jean‐Eric Charoin, Marianne Gerber,

International Journal of Clinical Pharmacology and Therapeutics

2005

24

Population Pharmacokinetic/Pharmacodynamic Model for C.E.R.A. in Both ESA‐Naïve and ESA‐Treated Chronic Kidney Disease Patients With Renal Anemia

Pascal Chanu, Ronald Gieschke, Jean‐Eric Charoin,

The Journal of Clinical Pharmacology

2010

22

Novel modelling approaches to predict the role of antivirals in reducing influenza transmission

Jason Asher, Annabelle Lemenuel‐Diot, Matthew Clay,

PLoS Computational Biology

2023

10

Page 1